通过调节FANCI FANCI,SSX2IP促进乳腺癌细胞的增殖和迁移
Xianfu Liu1, Xiaojing Zhang1, Yansong Chen1
1Department of Surgical Oncology, the First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
Cell biology international
|November 13, 2024
概括
突肉瘤X断点2相互作用蛋白 (SSX2IP) 通过上调FANCI促进乳腺癌的进展. 沉默SSX2IP可以抑制瘤生长,扩散和转移,这表明SSX2IP是潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 突肉瘤X断点2相互作用蛋白 (SSX2IP) 与癌症进展有关.
- 目前尚不清楚SSX2IP在乳腺癌中的特定作用和机制.
研究的目的:
- 研究SSX2IP在乳腺癌进展中的功能作用和分子机制.
- 探索SSX2IP作为乳腺癌的潜在治疗点.
主要方法:
- 免疫组织化学,qRT-PCR,以及西式涂抹,以评估基因表达.
- 在体外功能测定 (细胞计数,流细胞计量,迁移,入侵) 和体内瘤异种移植实验.
- 协同表达分析和协同免疫沉降 (Co-IP) 来研究蛋白质相互作用.
主要成果:
- 在乳腺癌组织中,SSX2IP被上调,并促进恶性表型.
- 在实验室中,SSX2IP Knockdown 抑制了增殖,迁移,并诱导了亡,并在体内抑制了瘤的生长.
- SSX2IP积极调节FANCI表达,FANCI过度表达部分逆转SSX2IP的淘汰效应.
结论:
- 通过调节FANCI,SSX2IP驱动乳腺癌的进展.
- SSX2IP代表了一种潜在的新生物标志物和乳腺癌治疗的治疗标.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


